MCM
GH icon

Moore Capital Management’s Guardant Health GH Stock Holding History

Moore Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-139,200
Closed -$7.49M – 582
2022
Q3 		$7.49M Buy
139,200
+6,100
+5% +$313K 0.18% 112
2022
Q2 		$5.37M Buy
+133,100
New +$6.59M 0.14% 153

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Moore Capital Management's GH Position: Q2 2022 in Review

Moore Capital Management sold out of Guardant Health (GH) in Q2 2022, closing a stake of 22,943 shares — an estimated $1.14M sold.

Moore Capital Management first reported a position in GH in Q2 2020 and held it in 8 quarters. The position peaked at $52.3M in Q3 2021. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

  • Moore Capital Management reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
  • Moore Capital Management sold 22,943 Guardant Health shares in Q2 2022, an estimated $1.14M.
  • Moore Capital Management first reported a position in Guardant Health in Q2 2020 and held it in 8 quarters.
  • Moore Capital Management's Guardant Health position peaked at $52.3M in Q3 2021.
  • 332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Moore Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.